human bmp6 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
human bmp6
Human Bmp6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 114 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+bmp6+protein/Recombinant+Human+BMP-6+Protein/us12612452-522-3-6
Average 95 stars, based on 114 article reviews
Human Bmp6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 114 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+bmp6+protein/Recombinant+Human+BMP-6+Protein/us12612452-522-3-6
Average 95 stars, based on 114 article reviews
human bmp6 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Recombinant:Article Title: Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses Article Snippet: .. Plasmids and reagents Article Title: Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses Article Snippet: Images of aortic rings were taken using an Olympus BX41 microscope (Olympus, Center Valley, PA) at day 6. .. Article Title: LIMK1 is Involved in the Protective Effects of Bone Morphogenetic Protein 6 Against Amyloid-β-Induced Neurotoxicity in Rat Hippocampal Neurons Article Snippet: Bone morphogenetic protein 6 (BMP6) has neuroprotective effects against various neuronal injuries, but its effect on amyloid(A )-induced neurotoxicity remains unclear.. We exposed rat hippocampal neurons to different concentrations of A 25-35 to induce neurotoxicity, and then treated cells with BMP6 to assess the neuroprotective effects.. In vivo, we bilaterally injected A 1-40 into basal forebrain to simulate the neuropathological process of Alzheimer’s disease (AD), and explored changes in the expression of BMP6 and LIMK1. Article Title: Bone morphogenetic protein 6 affects cell-cell communication by altering the expression of Connexin43 in human granulosa-lutein cells. Article Snippet: Connexin 43 (Cx43)-coupled gap junctions in granulosa cells play an important role in follicular development, oocyte maturation, and corpus luteum maintenance.. Bone morphogenetic protein 6 (BMP6) is highly expressed in human oocytes and granulosa cells and is involved in the regulation of female reproduction.. Currently, whether oocyteand granulosa cell-derived BMP6 affects the expression of Cx43 and its related gap junction intercellular communication (GJIC) activity in human granulosa cells remains unknown. Article Title: SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells Article Snippet: The wild-type (control) HepG2 cells and SEC23B -silenced HepG2 stable clones were cultured in RPMI 1640 (Sigma Aldrich, Milan, Italy) supplemented with 10% ( v / v ) fetal bovine serum (Life Technologies), 100 U/mL penicillin (Life Technologies), and 100 mg/mL streptomycin (Life Technologies), at 37°C in humidified air/CO2 (19:1) atmosphere. .. Article Title: BMP6 attenuates oxidant injury in HK-2 cells via Smad-dependent HO-1 induction. Article Snippet: Article history: Oxidative stress is involved Received 16 November 2008 Revised 24 January 2009 Accepted 2 February 2009 Available online 23 February 2009 Article Title: Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in Mice. Article Snippet: .. Hep3B and murine primary hepatocytes were treated with 50 ng/mL Article Title: Bone Morphogenetic Protein 6 Induces Downregulation of Pentraxin 3 Expression in Human Granulosa Cells through the SMAD-Dependent Signaling Pathway in Women with Polycystic Ovary Syndrome Article Snippet: .. Antibodies and reagents |
![BMP (bone morphogenetic protein) 9 protects from IL (interleukin)-33–induced endothelial-to-mesenchymal transition (EndMT) and induces sST2 (soluble supression of tumorigenicity 2) expression in control pulmonary arterial endothelial cells (PAECs) in vitro. A , Representative immunofluorescent staining of PAEC for CD31 (endothelial marker), SM22α (smooth muscle protein 22-alpha; mesenchymal marker), and 4′,6-diamidino-2-phenylindole (DAPI; nuclei). Cells were treated with BMP9 (1 ng/mL), IL-33 (100 ng/mL), both, or left untreated (control [CTR]) for 3 days. Bar graphs show CD31 and SM22α intensity quantification (n=3). B , sST2 , ST2L , CTGF , and PAI-1 gene expressions in PAECs after 16-hour stimulation with TGF (transforming growth factor)-β (1 ng/mL), activin A (50 ng/mL), or untreated (CTR; technical replicates [t.n.]=3). C , sST2 , ST2L , ID1 , and ID3 gene expressions in PAECs after 3-hour stimulation with BMP4 (50 ng/mL), <t>BMP6</t> (50 ng/mL), BMP9 (1 ng/mL), BMP10 (1 ng/mL), or untreated (CTR; t.n.=3). Statistical analysis: 1-way ANOVA with the Tukey post hoc test; * P <0.05, ** P <0.01, and **** P <0.0001. Data are shown as mean±SD.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2782/pmc12822782/pmc12822782__hyp-83-e24916-g002.jpg)
![BMP (bone morphogenetic protein) 9 protects from IL (interleukin)-33–induced endothelial-to-mesenchymal transition (EndMT) and induces sST2 (soluble supression of tumorigenicity 2) expression in pulmonary arterial endothelial cells (PAECs) from patients with pulmonary arterial hypertension (PAH) in vitro. A , Representative immunofluorescent staining of PAH PAEC for CD31 (endothelial marker), SM22α (smooth muscle protein 22-alpha; mesenchymal marker), and 4′,6-diamidino-2-phenylindole (DAPI). Cells were treated with BMP9 (1 ng/mL), IL-33 (100 ng/mL), both, or left untreated (control [CTR]) for 3 days. Bar graphs show quantification of CD31 and SM22α intensity (technical replicates [t.n.]=3). B , sST2 , ST2L , CTGF , and Pai-1 gene expressions in PAH PAECs s after 16-hour stimulation with TGF (transforming growth factor)-β (1 ng/mL), activin A (50 ng/mL), or untreated (CTR; t.n.=3). C , sST2 , ST2L , ID1 , and ID3 gene expressions in PAH PAECs after 3-hour stimulation with BMP4 (50 ng/mL), BMP6 (50 ng/mL), BMP9 (1 ng/mL), BMP10 (1 ng/mL), or untreated (CTR; t.n.=3). Statistical analysis: 1-way ANOVA with the Tukey post hoc test; P <0.05, * P <0.01, ** P <0.001, and *** P <0.0001. Data are shown as mean±SD.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2782/pmc12822782/pmc12822782__hyp-83-e24916-g005.jpg)